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Abstract
Endoscopic ultrasound-guided biliary drainage (EUS-BD) has been developed 
as an alternative method for failed endoscopic retrograde cholangiopancreatog-
raphy (ERCP). EUS-BD can be divided into two main approach routes, such as 
transgastric or transduodenal approach. Also, EUS-guided hepaticogastrostomy, 
choledochoduodenostomy (CDS), and gallbladder drainage (GBD) have been 
reported. In this chapter, we described technical tips for each basic technique, 
including literature review. As advanced technique of EUS-BD, antegrade stone 
removal has been reported. More recently, electrohydraulic lithotripsy for bile 
duct stones under transluminal cholangioscopy guidance, hepaticojejunostomy 
stricture dilation through EUS-hepaticogastrostomy (HGS) route, or EUS-guided 
gastrojejunostomy has been reported. Although EUS-BD has various potential 
as treatment technique, treatment method should be selected for each patient’s 
conditions.
Keywords: EUS-guided biliary drainage, EUS-BD, EUS, endoscopic  
ultrasound-guided biliary drainage, ERCP, endoscopic retrograde 
cholangiopancreatography, PTBD, percutaneous transhepatic biliary drainage
1. Introduction
Biliary drainage under endoscopic retrograde cholangiopancreatography 
(ERCP) is the gold standard and is an established technique for malignant bili-
ary obstruction. However, successful selective biliary cannulation is not always 
obtained. In addition, if the case is complicated by malignant gastroduodenal 
obstruction or surgically altered anatomy preventing advance of the endoscope into 
the ampulla of Vater, ERCP itself may not be indicated. As an alternative biliary 
drainage technique, percutaneous transhepatic biliary drainage (PTBD) is another 
established technique. However, this alternative may also be contraindicated for 
patients with massive ascites and shows several disadvantages such as risk of self-
tube removal or cosmetic problems. Endoscopic ultrasound (EUS)-guided biliary 
drainage (BD) has recently been developed as a novel alternative biliary drainage 
technique. EUS-BD can be divided into two main approach routes: transgastric and 
transduodenal. In addition, EUS-guided hepaticogastrostomy (HGS), choledocho-
duodenostomy (CDS), and gallbladder drainage (GBD) have been reported. In this 
chapter, we provide technical tips for each basic technique and review the associ-
ated literature.
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2. EUS-guided biliary drainage
2.1 EUS-guided CDS
2.1.1 Indications
EUS-CDS is mainly attempted for patients with failed endoscopic balloon dila-
tion (EBD) excluded prospective clinical trial, as previously described [1, 2]. This 
procedure can be performed for obstructions in the middle and lower bile duct. This 
indicates that pancreatobiliary carcinoma is the main indication for EUS-CDS. EUS-
CDS is contraindicated in patients with surgically altered anatomy, such as a 
Roux-en-Y anastomosis or tumor invasion-associated duodenal obstruction through 
which an endoscope cannot be passed. In such cases, EUS-guided hepaticogastros-
tomy may be indicated. However, if the duodenal bulb is not involved, EUS-CDS 
can be performed in combination with duodenal stenting. Optimal indications 
regarding EUS-CDS versus ERCP for benign disease have not been defined, com-
pletely. Prospective randomized controlled studies between ERCP and EUS-CDS 
are therefore needed to assess the clinical efficacy of the procedure. Indications for 
EUS-CDS are the following: (1) failed EBD including inaccessibility of the Vater, 
such as that caused by malignant duodenal obstruction, (2) contraindications for 
percutaneous transhepatic cholangiography drainage (PTCD), and (3) middle or 
lower bile duct obstruction. EUS-CDS has recently been attempted as a first-line 
drainage technique. According to randomized controlled trials [3, 4], EUS-CDS 
offers similar safety to ERCP. In addition, EUS-CDS may result in fewer cases of 
tumor ingrowth but may also be associated with greater frequencies of food impac-
tion or stent migration. Further high-quality randomized trials are needed.
2.1.2 Technical tips
The EUS scope is introduced into the duodenum, turned slightly to the left, and 
angled downward to identify the common bile duct (CBD) on EUS. To avoid any 
intervening vessels, the CBD should be punctured using a 19-G needle under color 
Doppler guidance. Then, bile juice is aspirated to be ensure the biliary tract, and the 
contrast medium is injected to obtain image of the CBD. During this step, avoiding 
puncture of the duodenal mucosa [5, 6] and cystic duct is important. When a dou-
ble duodenal mucosal line is visualized on EUS, the CBD should not be punctured 
to avoid puncture and stenting through the double duodenal mucosa. To prevent 
this adverse event, a water-filling technique may be impactful [5]. After guidewire 
insertion, to insert the stent delivery system, dilation for the duodenal and CBD 
wall is sometimes needed. Various devices have been described for dilatation of the 
fistula after puncturing the CBD. The most common devices for transmural tract 
dilation are the dilator (6 to 10 Fr), balloon catheter (4–8 mm), and needle knife. 
Park et al. described that the overall complication rate for EUS-CDS and EUS-HGS 
was 27% (15/55) [7]. As risk factor for complication associated with EUS-BD 
(P = 0.01, HR 12.4, 95%CI, 1.83–83.5), the use of a needle knife for fistula dilation 
is identified. Because of the acute angulation of the scope, following deployment of 
the catheter at the duodenum, the needle knife points tangentially when deployed. 
This can lead to accidental incision with a chance of pneumoperitoneum or bleed-
ing. Therefore, the author’s conclusion is that fistula dilation should be avoided to 
prevent procedural complication. The next step is stent deployment (Figures 1–3).
Endoscopist can select both plastic and metallic stents during EUS-CDS as 
drainage device. Plastic stents with diameters ranging from 5 to 10 Fr were com-
monly used according to previous reports. A 7- or 8.5-Fr plastic stent is used, 
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because the diameter of the working channel is 3.7 mm. However, bile leakage can 
occur with plastic stent placement (Figure 6). This patient experienced high fever 
and abdominal pain for up to 3 days after EUS-CDS, and bile leakage was seen 
according to computed tomography and duodenoscopy. If a large fistula is created 
before stent deployment, bile leakage from the gap between fistula and the stent 
is likely to occur because plastic stent is fine gauge compared with metal stent. On 
the other hand, although no comparative studies appear to have been conducted, 
metallic stents are expected to offer several clinical benefits. First, because of their 
large diameter, metallic stents tend to remain in the patent longer than plastic 
stents.
Second, bile leakage is less likely because of the close proximity between the 
metallic stent and duodenal and bile duct wall. If an uncovered metallic stent 
is used, however, bile leakage can easily occur, which sometimes proves fatal. 
Therefore, covered self-expandable metal stents (SEMSs) should be used. However, 
although SEMSs can prevent bile leakage, the side branch of biliary tract may be 
occluded. This suggests that if the distance between the puncture site and hepatic 
Figure 1. 
The common bile duct is punctured using 19-G needle from the duodenal bulb.
Figure 2. 
The covered metal stent deployment is performed from the common bile duct to the duodenum.
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hilar portion is short, a partially covered SEMS should be selected to prevent occlu-
sion of the intrahepatic bile duct. However, if EUS-CDS is performed using by a 
partially covered SEMS, bile leakage can occur from the uncovered site, particularly 
between the bile duct and duodenum. A challenging complication is stent migration 
during EUS-BD. In the use of a standard metallic stent in EUS-CDS, some authors 
have found that a double-pigtail plastic stent should be placed inside the metal 
stent to prevent stent migration. To prevent stent migration, standard SEMSs with 
a wide flange should be used, and stent shortening to a length of 60 mm may be 
preferable. Recently, a novel SEMS has been available. The lumen-apposing metal 
stent (LAMS) (NAGI Stent; Taewoong Medical Co., Seoul, Korea) is a 10.5-Fr 
delivery system and consists of a fully covered, 20-mm-long, 16-mm-diameter 
stent. The hot AXIOS stent (Xlumena, Inc., Mountain View, CA, USA) is a fully 
covered, 10-mm-diameter delivery system, with 10-mm-long braided stent with 
bilateral 20-mm-diameter anchor flanges. These novel SEMSs are mainly used for 
EUS-guided pseudocystic drainage and EUS-guided cholecystogastrostomy [8–10]. 
These SEMSs also seem useful for EUS-CDS, although clinical trials are needed to 
confirm their utility.
2.1.3 Clinical results
According to a recent meta-analysis including 572 patients [11], the pooled 
rate of all adverse events was 0.136 (95% CI, 0.097–0.188; P = 0.01) with moder-
ate heterogeneity (I = 56.9), and pooled rates were 4.2% for cholangitis, 4.1% for 
bleeding, 3.7% for bile leakage, and 2.9% for perforation. On subgroup analysis, the 
pooled rate of adverse events with the use of lumen-apposing metal stents was 9.3% 
(95%CI, 4.8–17.3%). On the other hand, the rate of adverse events such as cholangi-
tis, bleeding, and bile leakage was 13.4%.
2.2 EUS-guided HGS
2.2.1 Indications
EUS-HGS should be indicated for failed ERCP due to surgical anatomy or 
inaccessible ampulla of Vater, because adverse events such as stent migration 
can sometimes prove fatal. However, although EUS-CDS cannot be attempted in 
patients complicated with surgical anatomy, such as Roux-en-Y anastomosis or 
Figure 3. 
Metal stent is placed in the duodenum bulb.
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malignant duodenal obstruction, EUS-HGS can be attempted because the access 
route of EUS-HGS is the stomach. Regarding biliary stricture sites, EUS-HGS 
may be challenging in case of hepatic hilum stricture because stent deployment is 
performed from the left intrahepatic bile duct. Therefore, the right hepatic bile duct 
cannot drain. As expanding indication, EUS-BD for right hepatic bile duct obstruc-
tion has been developed [12, 13]. Park et al. [12] reported that EUS-guided biliary 
access is successfully performed in antegrade bypass stenting (n = 2), antegrade 
transanastomotic stenting (n = 1), antegrade transanastomotic balloon dilation 
(n = 1), and the use of the cholangiogram as a roadmap (n = 1) among six patients 
with isolated right hepatic bile duct obstruction. We also conducted that EUS-BD 
was successfully performed using bridging method (n = 7) and locking stent 
method (n = 4) among 11 patients with right hepatic bile duct obstruction [13]. 
No severe adverse events were identified in either study. EUS-HGS has potential 
as indication for hepatic hilar stricture. However, because it is technically chal-
lenging, the right hepatic approach under EUS guidance should be performed for 
selected patients. Recently, Khashab et al. [14] reported a comparative evaluation 
of PTCD and EUS-BD in patients who were complicated with distal malignant 
biliary obstruction. According to this study, although the technical success rate was 
higher in the PTCD than in EUS-BD (100% vs. 86.4%, P = 0.007), clinical success 
and stent patency were not different. Rates of adverse event (70.6% vs. 18.2%, 
P < 0.001) and total charges were significantly higher in the PTCD ($9.072 ± 3.817 
vs. $18.261 ± 16.021, P = 0.003). Therefore, their conclusion is that EUS-BD might 
be preferred if EUS-BD can be performed by experienced endoscopists. However, 
there are several limitations such as small number of patients, a single-center study, 
and a single operator. Therefore, to determine whether EUS-HGS or PTCD should 
be performed in a multicenter, prospective randomized controlled study is needed. 
The current indications for EUS-HGS are the following: (1) failed ERCP, (2) inac-
cessibility of the Vater due to surgical anatomy or duodenal obstruction caused by 
the tumor, and (3) contraindications for PTCD due to massive ascites and risk of 
self-tube removal. Compared with PTCD, metallic stent placement can be used in 
EUS-HGS in primary session. Therefore, EUS-HGS may be indicated even if a small 
amount of ascites is present in the access route. However, if massive ascites is pres-
ent, preventing the formation of fistula between the stomach and liver, EUS-HGS 
is not indicated. The contraindications for EUS-HGS are the following: (1) massive 
ascites between the stomach and liver and (2) unresectable gastric cancer.
2.2.2 Technical tips
The EUS device is introduced into the stomach. Then, using counterclockwise 
rotation, the left hepatic lobe can be identified. A 19-G FNA needle may be better 
than a 22-G. A stiffer guidewire is inserted into the biliary tract through the 
EUS-fine needle aspiration (FNA) needle because fistula dilation is an important 
point to insert the stent delivery system compared with EUS-CDS. If segment 2 
(B2) is punctured, because devices can be passed across the mediastinum, when 
puncturing from the esophagus, severe adverse events such as mediastinitis or 
pneumomediastinum may occur. Therefore, segment 3 (B3) should be initially 
punctured. There are two important points regarding the intrahepatic bile duct 
puncture. The first point is the angle of the bile duct, and the second point is the 
volume of the liver parenchyma. The bile duct that runs from the upper left to the 
lower right based on EUS imaging should be punctured to advance the guidewire 
toward the hepatic hilum. Furthermore, avoiding stent migration into the abdomi-
nal cavity requires a sufficient volume of liver parenchyma to obtain anchoring 
function, like PTCD procedure. Therefore, B3 is better as puncturing site. The next 
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step is guidewire insertion. During EUS-HGS, one of the most important proce-
dures is the guidewire insertion. If the guidewire is introduced into the peripheral 
biliary tract, the next step may not be attempted. The biliary tract running from 
the upper left to the lower right on EUS imaging should be punctured to success-
fully advance the guidewire toward the hepatic hilum, as described in the above 
section. If the guidewire is advanced into the periphery of the biliary tract, the 
guidewire should be pulled, and then advance of the guidewire into the hepatic 
hilum should be attempted. However, during this procedure, the guidewire is 
sometimes kinked with the FNA needle. To avoid this adverse event, the liver 
impaction method appears clinically impactful [15]. Various types of guidewire are 
available. A 0.025-inch guidewire with a highly flexible tip, sufficient stiffness, 
and easy seeking ability is preferable for EUS-guided procedures. After the guide-
wire is inserted along with other devices, continued visualization of the other 
devices on EUS imaging is important during various EUS-guided procedures to fit 
the alignment. To perform stent deployment, the bile duct and stomach wall must 
be dilated. Various techniques for dilating a fistula have been reported to date 
[16–20]. A graded dilation technique using a dilator or a 4-mm balloon catheter is 
used by many authors according to previous studies. The mechanical dilator (6 to 
10 Fr), balloon catheter (4–8 mm), and needle knife are mainly selected by many 
authors. Park et al. [16] described that, among the total of 57 patients who under-
went EUS-BD, post-procedural adverse events such as bile peritonitis (n = 2), mild 
bleeding (n = 2), and self-limited pneumoperitoneum (n = 7) were observed. 
According to multivariate analysis, the use of a needle knife was the only risk factor 
for post-procedure adverse events of EUS-BD (P = 0.01, HR 12.4, 95%CI, 1.83–
83.5). Therefore, their conclusion is that a needle knife should not be selected as a 
dilation device. To avoid this risk, an electrocautery dilator, which was coaxial with 
the guidewire, has been developed. Although this device is clinically useful as a 
dilation device, this device has disadvantages such as burning effect. When the bile 
duct is punctured while avoiding small vessels using color Doppler, bleeding can 
occur due to the burning effect of the electrocautery dilator. To reduce burning 
effects, a novel electrocautery dilator has become available in Japan (Fine 025; 
Medico’s Hirata Inc., Japan, Osaka) [17]. Further study is needed to evaluate this 
device. On the other hand, a graded dilation technique using a balloon or mechani-
cal dilator may be safe because burning effect does not occur. Park et al. [18] 
reported that graded dilation using a 4-Fr catheter and 6- or 7-Fr bougie dilator 
device is safe. In this study, technical success rate of EUS-CDS was high, with a low 
rate of adverse events. According to our previous report [19], we reported success-
ful EUS-HGS using an ERCP catheter and a 4-mm balloon catheter without using 
electrocautery devices. This technique may be associated with a lower frequency of 
bleeding caused by the burning, although bile leakage might easily occur during 
graded dilation because procedure time is longer. Recently, novel techniques and 
dilation devices for EUS-BD have been reported. Paik et al. [20] reported a simpli-
fied fistula dilation technique. After the biliary tract was punctured using a 19-G 
FNA needle, direct insertion using a 4-mm balloon catheter was performed. In 28 
patients, the technical success rate was 96% (27/28). In addition, early adverse 
events were not seen in any patients. We also described a simplified fistula dilation 
technique using a fine-gauge balloon catheter [21, 22]. As an even more novel 
technique, a one-step stent placement technique has been described [23]. 
According to this study, 32 patients, who were complicated with malignant biliary 
stricture, were enrolled. EUS-BD was performed using a novel metallic stent. The 
introducer for this novel stent has only a 3-Fr-tip-4-Fr tapered. The technical 
success rate of one-step stent deployment was 88% (14/16). In addition, the 
procedure time was short in the one-step stent placement group. The risk of bile 
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leakage may be increased, if procedure time is longer. In fact, in their reports, 
although significant differences were not seen, early adverse events were uncom-
mon in the one-step dilation group compared with the graded dilation group 
(31.3% vs. 6.3%, P = 0.172). Although randomized, clinical trials and additional 
cases are needed to clarify which dilation technique or devices are more suitable in 
EUS-HGS, these techniques have potentials of decreasing the frequency of adverse 
events such as bile leakage. The final step is stent deployment. A fully covered 
self-expanding metal stent (FCSEMS) with strong radial force may be suitable for 
EUS-HGS compared with a plastic stent for the following reasons: (1) if a large 
fistula is created before inserting the stent delivery system, bile leakage from the 
gap between the stent and fistula the fistula is less likely; (2) longer stent patency 
may be obtained due to large diameter compared with plastic stent; and (3) a 
tamponade effect of stent expansion may occur if bleeding from the stomach wall 
is present. However, the following disadvantages are seen for FCSEMS: (1) the 
stent is expensive; (2) stent shortening must be considered during stent deploy-
ment, especially in the luminal portion to prevent stent migration into the abdomi-
nal cavity; and (3) side branches may be obstructed by covered site of the metal 
stent [24]. A novel metallic stent and several efforts to prevent stent migration have 
been recently reported. Some authors have described that a double-pigtail plastic 
stent can be placed inside the metal stent, when standard metallic stents are used. 
Prevention of stent dislocation requires sufficient stent length. We have also 
described that EUS-HGS can be safely performed using a partially covered metallic 
stent with long length [25]. More recently, Song et al. [26] described a preliminary 
study on a newly hybrid metal stent in EUS-BD procedure. The distal portion of 
this stent, which is 3.5-mm long, comprises silicone-covered nitinol wire to prevent 
bile leakage through the mesh. Also, anti-migration flaps are present proximal and 
distal to the covered site to prevent stent migration into the abdominal cavity. This 
novel stent, on the proximal site, has the uncovered site. This uncovered site is 
1.5- to 5.5-mm long. This fact can prevent bile duct branch obstruction. In their 
study using this novel hybrid stent, EUS-HGS was successfully attempted for all 10 
patients. In addition, no bile leakage or stent migration was seen in any patients. 
On the other hand, EUS-HGS using a newly designed plastic stent has been 
described by Umeda and Itoi et al. [27] that report using an 8-Fr single-pigtail 
plastic stent, which is a push-type stent that is usually not possible to retract (total 
length, 20 cm; effective length, 15 cm; four flanges). Also, the proximal end has a 
pigtail structure, and the distal end is strongly tapered. EUS-HGS using this plastic 
stent was successfully attempted in all 23 patients. Although bleeding or abdominal 
pain was seen in four patients (17.4%), no severe adverse events such as stent 
migration into the abdominal cavity or stent dislocation were observed during 
follow-up (median 5.0 months). Median stent patency was 4.0 months, and 
therefore, this result was clinically encouraging. However, as the author described 
in this report, additional long-term studies with a larger number of cases are 
needed to clarify the clinical benefit of using this stent for EUS-HGS. To prevent 
stent migration, technical tips for stent deployment are also extremely important. 
One of the consensus techniques in Japan is the intra-scope channel release tech-
nique [28]. The following steps were followed for stent release under the intra-
scope channel technique. The stent delivery system was inserted into the 
confluence of B2 and B3. Next, stent release was performed from the intrahepatic 
bile duct to the hepatic parenchyma. Thereafter, the EUS scope was stabilized until 
the stent was deployed up to 1 cm within the EUS scope. The EUS scope was then 
withdrawn slightly while simultaneously pushing the stent delivery system. In that 
procedure, stent release was performed completely under endoscopic guidance 
(Figures 4–6).
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2.2.3 Clinical results
According to a recent meta-analysis of 686 patients [29], overall clinical success 
and technical success rates were, respectively, 84% (95%CI 80–88%) and 96% 
(95%CI, 93–98%) for EUS-HGS. On the other hand, in terms of technical results for 
EUS-HGS conducted by non-expert hands, the technical success rate was only 64.7% 
(22/34) [30]. This technique should therefore be performed in expert-assisted situ-
ations, and improvement of devices is warranted. The rate of adverse events includ-
ing bile leakage, stent migration, bleeding, and peritonitis was relatively high (29%).
Figure 5. 
The covered metal stent deployment is performed from the intrahepatic bile duct to the stomach.
Figure 4. 
The intrahepatic bile duct is punctured using 19-G needle from the stomach.
Figure 6. 
The metal stent is placed in the stomach.
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2.3 EUS-guided gallbladder drainage (GBD)
2.3.1 Indications
Compared with percutaneous transhepatic gallbladder drainage (PTGBD), 
one of the advantages of EUS-GBD is internal drainage. In addition, the procedure 
is technically simple compared with endoscopic retrograde gallbladder drainage 
(ETGBD). However, the results of long-term follow-up remain unclear, and there is 
still insufficient evidence on the performance of EUS-GBD as the first-line drainage 
technique. Current indications for EUS-GBD are thus as follows: (1) nonsurgical 
candidates with/without stone extraction, (2) as a bridge to surgical cholecystec-
tomy, (3) conversion from PTGBD to EUS-GBD, (4) alternative to failed PTGBD/
ETGBD, and (5) alternative to failed EUS-guided biliary drainage such as EUS-CDS 
or HGS [31].
2.3.2 Technical tips
The EUS probe is advanced into the stomach or duodenum to identify the 
gallbladder. The gallbladder neck is normally detected from the duodenal bulb, and 
the body or tail of the gallbladder is also detected via the stomach. No evidence of 
clinical differences between the use of these two sites has been found in previous 
reports. Tyberg et al. conducted a clinical study of differences between transgastric 
and transduodenal approaches regarding EUS-GBD [32]. In this study including a 
total of 42 patients, technical success was achieved in 92.6% (25/27) in transgas-
tric approach group and in 100% in the transduodenal approach group. Adverse 
events were observed in four patients in the transgastric approach group (14.8%) 
and in five patients in the transduodenal approach group (33%). Therefore, they 
concluded that stent location was not a significant predictor of clinical failure 
(P = 0.432) or adverse events (P = 0.289). Also, Teoh et al. performed a comparative 
analysis of EUS-GBD from the antrum route or duodenum route [31]. Among a total 
of 59 patients, technical and clinical success rates were 94.4% (34/36) and 91.2% 
(31/34), respectively, among patients who underwent EUS-GBD from the antrum 
and 100% (23/23) and 95.7% (22/23) among patients who underwent EUS-GBD 
from the duodenum (P = 0.52 and 0.39). Overall adverse events also showed no 
significant difference between the two groups (P = 0.64). Endoscopists are thus 
free to select the site preferred for puncture. However, the duodenum may have less 
mobility compared with the stomach. This may result in less technically challenging 
and lower risks of both early and late stent migration with the transduodenal route. 
In addition, the frequency of food reflux into the gallbladder through the EUS-GBD 
stent may be lower when puncture is attempted via the duodenum compared with 
the stomach [33, 34]. On the other hand, EUS-GBD from the stomach may have 
several benefits. First, because the lumen is normally larger in the gallbladder body 
than in the gallbladder neck, puncturing the gallbladder through the stomach may 
be easy. In particular, the gallbladder body allows a greater lumen area to accom-
modate the internal flanges of the LAMS. Second, if serious complications such as 
perforation or stent migration occur, the consequences may be less serious because 
subsequent surgery is easier in patients who have undergone EUS-GBD from the 
stomach compared with from the duodenum. Endoscopists should thus be mindful 
of the characteristics of each site before performing EUS-GBD (Figures 7 and 8).
The next step is fistula dilation. According to previous reports [33, 35–42], a 6- 
or 7-Fr bougie, tapered catheter, and 4-mm balloon were the most commonly used 
devices for dilatation prior to insertion of drainage devices. If some resistance to 
passage of the stent delivery system is present, electrocautery dilation may be useful 
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according to previous reports. Bile leakage may occur as with other EUS-BD proce-
dures, after this step and prior to stent deployment. In fact, the risk of bile leakage is 
frequently observed compared with EUS-HGS, because of the lack of a tamponade 
effect from the liver. As a result, dilation with one-step process may be preferred. 
Electrocautery dilation can certainly be performed regarding dilation of the fistula; 
however, it carries a risk of burns, which can in turn lead to bleeding. A dilation 
technique using a fine-gauge balloon catheter may be suitable from the perspective 
of preventing adverse events. However, since no evidence suggests which dilation 
devices should be used, a randomized controlled study among various dilation 
devices should be attempted.
Recently, the hot AXIOS stent with electrocautery-enhanced delivery system 
(Boston Scientific, Marlborough, MA, USA) has been developed. This stent is a 
through-the-scope LAMS mounted on a stent delivery system with an electrocau-
tery wire at the distal tip. The electrocautery tip allows passage of the catheter into 
the gallbladder without the need for prior dilation of the tract by application of a 
pure cutting current. This fact may have clinical benefits, such as shortening of 
Figure 8. 
The covered metal stent deployment is performed from the gallbladder to the duodenum.
Figure 7. 
The gallbladder is punctured using 19-G needle from the duodenum.
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the procedure time, reduced bile leakage during fistula dilation, and an improved 
technical success rate due to the single-step nature of the procedure. However, a 
previous retrospective study [31] showed no significant differences in technical 
success rates between hot and cold AXIOS [100% (10/10) vs. 95.9% (47/49), respec-
tively; P = 1.00]. In addition, rates of adverse events were not significantly different 
[20% (2/10) vs. 34.7% (17/49), respectively; P = 0.48]. Since electrocautery dilation 
procedures may carry a risk of bleeding due to the potential for burns, a random-
ized controlled trial is needed to determine the superiority of hot AXIOS.
The next step is stent deployment. EUS-GBD has been performed using plastic 
stents. However, because stent deployment in EUS-GBD is performed from the 
gallbladder to the stomach or duodenum through the abdominal cavity, no tampon-
ade effect arises such as due to the hepatic parenchyma, as seen with EUS-HGS. Bile 
leakage can therefore occur due to the gap between the fistula and plastic stent. 
In addition, stent patency is shorter compared with the covered SEMS (cSEMS). 
Jang et al. reported a comparative trial between EUS-GBD and PTGBD for acute 
cholecystitis [38]. In a study including 29 patients, who underwent EUS-GBD, 
laparoscopic cholecystectomy was performed in 23 patients (79.3%). None of the 
patients initially underwent open cholecystectomy, although 2 of the 23 patients 
(8.7%) in the EUS-GBD group and 3 of 26 patients (11.5%) in the PTGBD group 
required conversion to open cholecystectomy (P = 0.99). They also described 
that EUS-GBD did not cause severe inflammation or adhesions to the tissues 
surrounding the gallbladder and laparoscopic cholecystectomy could be safely 
attempted following EUS-GBD using plastic stents or endoscopic naso-gallbladder 
drainage (ENGBD) without an increase in technical difficulty as compared with 
PTGBD. Therefore, the use of a plastic stent should first be considered, if the 
patient is likely to undergo cholecystectomy in the future. Recently, cSEMS has been 
used as the drainage device for EUS-GBD instead of plastic stents in patients who 
are not good candidates for surgery due to other severe organ failure or the pres-
ence of advanced malignancy. The cSEMS is useful as compared with plastic stents, 
since self-expanding stents prevent bile leakage and are associated with longer stent 
patency. However, because of weak flanges, the standard tubular cSEMS has a risk 
of stent migration after stent deployment. As a method to prevent stent migration, 
several authors have described combination usage of a double-pigtail plastic stent or 
ENGBD and cSEMS [33, 39, 40, 42]. Indeed, stent migration has not been observed 
in EUS-GBD cases using this technique. And if the cSEMS migrates, the pigtail 
plastic stent remains in place from the gallbladder to the gastrointestinal lumen. 
This maintains fistula patency, allowing re-intervention.
Khan et al. undertook a systematic review of endoscopic gallbladder drainage 
[43]. In this review, subgroup analysis was attempted regarding the kinds of stent 
in the EUS-GBD. According to their results, EUS-GBD using SEMS is less likely to 
cause adverse events than EUS-GBD using a plastic stent or ENGBD. Therefore, if 
the patient is unlikely to undergo future cholecystectomy, EUS-GBD using SEMS 
might be preferable to prevent adverse events.
LAMS deployment has been reported in EUS-guided transluminal interven-
tions, including EUS-guided pancreatic fluid collection [44], EUS-guided bile duct 
drainage [45], and EUS-guided gastroenterostomy [46]. LAMS has several benefits 
compared with SEMS. LAMS has a larger inner diameter, allowing better drainage. 
Also, the unique design such as the form of anchoring flanges may play an impor-
tant role in preventing stent migration into both abdominal and luminal portions. 
Finally, a standard endoscope can be passed into the gallbladder lumen through 
the LAMS after LAMS deployment. In cases requiring EUS-guided intervention 
for walled-off necrosis [47], the use of SEMS or LAMS is superior to plastic stents 
in terms of overall treatment efficacy. The number of procedures required was 
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significantly lower with LAMS compared with SEMS or plastic stent placement. 
However, since high-quality evidence is lacking regarding the use of LAMS in EUS-
GBD procedures, comparative studies between LAMS and other drainage devices 
for EUS-GBD are needed.
Finally, this chapter referred to our previous papers [48–50].
3. Conclusions
EUS-guided biliary drainage has clinical impact as alternative drainage tech-
nique. If more evidences are available, indications of this technique will be spread.
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